Home > Companies > Arcus Biosciences

Arcus Biosciences

Arcus Biosciences is an exciting young company founded on a vision of creating new cancer therapeutics through the utilization of emerging insights in immunology. Arcus was formed in 2015 by a group of seasoned researchers from the biotechnology and pharmaceutical industries and is located in the San Francisco bay area, in the heart of the world’s largest biotechnology research hub. Unlike many other organizations, we view the drug discovery process as one that requires equal parts of technology and art, science and elegance, not as a commodity that can be outsourced. For this reason, we have assembled and are continuing to build an internal team of uniquely qualified individuals with extraordinary knowledge, skills and drive.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

Oil Gas and Petroleum Refinery

Conference

Polymer Physics for Sustainability

Conference

Material Polymer Science and Engineering

Conference

Plastics Recycling Technology

Conference

8th International Conference on Polymer Science and Technology

Conference

International Conference on Oil, Gas and Petroleum Engineering

Conference

Related News

CHEMICAL FIRMS TO INVEST IN YOUNG CHINESE TECH COMPANIES

BASF, Evonik | July 27, 2020

Chemical firms’ search for growth is taking them to China to invest in young companies with new technology. BASF and Evonik Industries are backing SmartAHC, an animal health monitoring start-up based in Chengdu and Shanghai. SmartAHC is targeting pig farms for its networked monitoring devices and software that use artificial intelligence to identify individual pigs, track their location, and measure their temperature and fertility. It can help farmers detect and isolate sick animals to pre...

CHEMICAL MANAGEMENT

SI GROUP SIGNS AGREEMENT TO SELL ITS INDUSTRIAL RESINS BUSINESS TO ASK CHEMICALS

SI Group | July 26, 2021

SI Group, a leading performance additives company, said today that it intends to close the deal to sell the majority of its global Industrial Resins business to ASK Chemicals, a portfolio company of private equity firm Rhône Group, LLC. SI Group's Industrial Resins products and related production facilities in Rio Claro, Brazil; Ranjangaon, India; and Johannesburg, South Africa, as well as licensed technology and numerous tolling agreements worldwide, are included in the...

CHEMICAL TECHNOLOGY

WESTLAKE TO ACQUIRE DIMEX

Westlake | August 05, 2021

Westlake Chemical Corporation, today announced plans for one of its subsidiaries to acquire the parent company of Dimex LLC, from Grey Mountain Partners, a private equity firm. Based in Marietta, Ohio, Dimex produces a variety of consumer products made from post-industrial-recycled (PIR) polyvinyl chloride (PVC), polyethylene (PE) and thermoplastic elastomer (TPE) materials, and has annualized sales of approximately $100 million. These consumer products include landscape edging; industrial, home...

CHEMICAL MANAGEMENT

RIPPLE INC. AND CARBONCURE TECHNOLOGIES SIGN A CARBON CREDIT PURCHASE AGREEMENT FOR CO₂ STORAGE

Invert Inc. | April 13, 2022

Recently, Invert Inc., CarbonCure Technologies, and Ripple Inc. have signed a revolutionary carbon credit purchase agreement for permanent CO2 storage through carbon mineralization. They have stepped forward following the announcement by the United Nations' Intergovernmental Panel on Climate Change of the critical need for carbon removal technologies to mitigate the worst effects of climate change. The credit purchase will permit CarbonCure to invest more in innovative technol...